Our team

A passionate group of experts, working together to accelerate precision medicine

Board of Directors

Our Board of Directors is focused on ensuring the overall success of the business, and provides experienced and committed leadership

Dr Jan Groen

Executive Chairman

Kim Oreskovic

Non-executive Director and Audit Committee Chair

Klaas De Boer

Senior Independent Non-executive Director and RemCo Chair

Benjamin Hart

Non-executive Director

Peter Collins

Chief Executive Officer

Management team

Our Management team each bring a wealth of experience from their own field of expertise and together provide daily guidance and leadership across the whole of the company

Dr Jan Groen

Executive Chairman

Peter Collins

Chief Executive Officer

Lavanya Sivapalan

Senior Director of R&D and Service Laboratories

Michelle Munson

Chief of Staff

Sinéad Armstrong

Finance Director

Scientific Advisors

The Scientific Advisory Board (SAB) is comprised of a group of individuals that have significant scientific technical backgrounds in medical devices, diagnostics and other areas related to CelLBxHealth’s products. SAB members provide strategic input, insight and expertise in the blood and cancer fields and also advise the Company on technical aspects in relation to platform development, product development and clinical studies as well as providing broader industry input.

Dr. Daniel Danila

Medical Oncologist, Memorial Sloan Kettering Cancer Center

Dr. James M. Reuben

Professor, Department of Hematopathology, MD Anderson Cancer Center

Prof. Greg L Shaw

Consultant Urological Surgeon, University College Hospitals NHS Foundation Trust

Dr. Harold Swerdlow

Independent Consultant, Inventor of Illumina NGS technology

Discover how CelLBxHealth can help with your liquid biopsy needs

Contact us

Request a meeting with